Applied Biosciences Corp.
APPB
$0.00
$0.000.00%
| 12/31/2019 | 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | |
|---|---|---|---|---|---|
| Net Income | -74.03% | -83.46% | -83.03% | 87.76% | -1,613.59% |
| Total Depreciation and Amortization | 58.69% | 0.00% | 0.00% | 13,133.33% | 0.00% |
| Total Amortization of Deferred Charges | 150.52% | 31.36% | -64.80% | -84.18% | 866.01% |
| Total Other Non-Cash Items | 14,056.00% | 91.53% | 9.65% | -105.68% | 713.22% |
| Change in Net Operating Assets | 34.68% | 1,465.32% | -71.72% | 152.54% | -219.23% |
| Cash from Operations | 85.78% | 8.15% | -243.37% | 76.54% | -276.73% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 70.60% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 70.31% | -- |
| Total Debt Issued | -100.00% | 3.10% | 358.71% | -93.36% | 848.15% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 3.10% | 358.71% | -93.36% | 848.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -246.76% | 490.11% | 95.32% | -182.91% | 6,602.86% |
